You may read about the benefits of an ESCMID membership and sign up online. You also find information on ESCMID’s organizational structure of, partnerships with other organizations as well as the society´s bylaws.
The Calendar lists upcoming congresses, conferences and educational courses organized or endorsed/promoted by ESCMID. You can find information on past events in the archive. Material from these events can be found in the ESCMID eLibrary.
Candida auris is a new species of Candida that is currently causing outbreaks in healthcare settings worldwide. The first outbreak in Europe was described in England in 2015, but there are already cases in Spain. C. auris is difficult to identify with classical methods and can be misidentified with different species (Rhodotorula glutinis, Saccharomyces cerevisiae, Candida haemulonii, Candida sake, or other species of Candida non-albicans), according to the identification method used. Correct identification can be done by sequencing the ITS or D1-D2 regions or with MALDI-TOF (the species has been included in the last update of Bruker´s library). C. auris is resistant to fluconazole, and strains resistant to amphotericin B and echinocandins have also been described. From the experience acquired so far, it is known that it is important to detect it as soon as possible to take control measures, due to its high transmission capacity and resistance pattern. Due to the difficulty of the correct identification of C. auris, if proper identification methods are not available we recommend the referral of suspected invasive isolates to a reference mycology laboratory. For more information you can visit the following links:
Risk Assessment of the European Center for Disease Control (ECDC, direct link)
Guidance for the laboratory investigation, management and infection prevention and control from cases of Candida auris elaborated by Public Health England (PHE, direct link)
EFISG comments on JAC supplement on antifungal stewardship
The Journal of Antimicrobial Chemotherapy on 2 November published a supplement on antifungal stewardship, which is a core element in patient care at hospitals. EFISG welcomes and supports this initiative and takes this opportunity to highlight these specific recommendations on antifungal stewardship (online access to this supplement). You may have a look at the supplement's table of content as well as EFISG's comment.
Sunday, 10 April 2016 9.00 h - 11.00 h (Hall J) 2-hour Symposium SY048: Approaches to individualized management of invasive fungal disease 11.30 h - 12.30 h (Hall K) 1-hour Symposium SY059: Recent top papers in mycology 13.15 h - 14.15 h (Room: G109) EFISG Meeting: All interested persons are cordially invited to join the meeting and plan future Study Group activities. 14.30 h - 15.30 h (Hall J) Keynote Lecture KL069: The fungal microbiome and human health
Monday, 11 April 2016 7.45 h - 8.45 h (Hall E104/105) Meet-the-Expert Session ME083: Antifungal stewardship: do we need it in our hospitals?
Tuesday, 12 April 2016 13.30 h - 15.30 h (Hall G) 2-hour Symposium SY148: How to diagnose more fungal disease and less colonization
This four-week course is intended for microbiologists (MD, PhD, VetD) practicing mycology in hospital laboratories to catch up with the most recent advances in diagnosis and identification procedures and principles of therapy for fungal infections.
Saturday, 25 April 2015 08.45 - 10.45 (Hall C) EFISG Educational Workshop EW03: Optimizing antifungal therapy - bridging laboratory and clinical expertise. 16.30 - 18.30 (Hall C) EFSIG Symposium SY07: Clinical approach in febrile immunocompromised patients with pulmonary infiltrates. Organized jointly with the International Immunocompromised Host Society (ICHS)
Sunday, 26 April 2015 14.30 - 15.30 (Hall H) EFISG Symposium SY20: Recent top papers in fungal infections. 16.00 - 18.00 (Hall D) EFISG Symposium SY24: Challenges in fungal infections 18.15 - 19.15 (Room 19) EFISG Business Meeting: All interested persons are cordially invited to join the meeting and plan future Study Group activities.
Tuesday, 28 April 2015 07.45 - 08.45 (Hall M) EFISG Meet-the-Expert Session ME17: How do I treat aspergillosis and mucormycosis? 11.30 - 12.30 (Hall H) EFISG Symposium SY50: Fungal PCR
Saturday, 10 May 2014 11.00 - 13.00 (Hall J) Educational Workshop 19: ESCMID guidelines for diagnosis and treatment of Aspergillus diseases, organised jointly with the ESCMID Study Group for Infections in Compromised Hosts (ESGICH); the European Confederation of Medical Mycology (ECMM); the European Respiratory Society (ERS) and the European Academy of Allergy and Clinical Immunology (EAACI).
Sunday, 11 May 2014 18.15 - 19.15 (Room 127/128) EFISG Business Meeting: All interested persons are cordially invited to join the meeting and plan future Study Group activities.
Monday, 12 May 2014 7.45 - 8.45 (Hall F) EFISG Meet-the-Expert Session: New nomenclature: new species - any meaning for clinical relevance? 11.30 - 12.30 (Hall C) EFISG Keynote Lecture: Fighting against fungal infections: cells on the front lines. 14.30 - 15.30 (Hall E) EFISG Symposium: T-cells in invasive aspergillosis. 16.00 - 18.00 (Hall A) EFISG Symposium: Cryptococcal infections in HIV-infected patients: what is new in 2014? Organised jointly with the European AIDS Clinical Society (EACS). 16.00 - 18.00 (Hall E) EFISG Symposium: Predicting the future in fungal diagnosis and therapy, organised jointly with the Mycology Study Group (MSG) of the International Society for Human and Animal Mycology (ISHAM).
Saturday, 27 April 2013 08.45 - 10.45 (Hall E) EFISG Educational Workshop 9 (jointly organised with ECMM): ESCMID/ECMM Guideline: diagnosis and therapy of rare and emerging fungi
Sunday, 28 April 2013 07.45 - 08.45 (Hall C) EFISG Meet-the-Expert Session (jointly organised with EUCAST): Do we need both, species identification and MICs to guide antifungal therapy? 14.30 - 15.30 (Hall C) EFISG Symposium (jointly organised with ESGCP): Azole resistance 18.15 - 19.15 (Hall 10) EFISG Business Meeting: All interested persons are cordially invited to join the meeting and plan future EFISG activities.
Tuesday, 30 April 2013 13.30 - 15.30 (Hall C) EFISG Symposium: Pneumocystis: the pathogens - clinical symptoms, diagnosis and management
For more details, please check the ECCMID programme.
31 March, 8.45-10.45 Educational Workshop EW01 "State-of-the-art management of infections following solid organ transplantation" Jointly arranged with EFISG and ESGICH.
31 March, 11.00-13.00 Educational Workshop EW11 "Common statements in the literature regarding invasive fungal diseases - truth or cliché" Arranged with EFISG and the European Organisation for Research and Treatment of Cancer (EORTC).
1 April, 9.00-11.00 2-hour Symposium "Diagnosing fungal diseases: future perspectives"
3 April, 7.45-8.45 Meet-the-Expert Session "Fungal taxonomy for the clinician in 2012"
1 April, 13.00-14.00 (Meeting Room 12) EFISG Business Meeting Minutes
For more details, please check the ECCMID programme.
7 May, 8.45-13.00 Educational Workshop EW02 "Fungi in the respiratory tract & antifungal stewardship" Arranged by EFISG/ECMM (European Confederation of Medical Mycology)/GRACE (Genomics to combat Resistance against Antibiotics in Community-acquired LRTI in Europe).
7 May, 11.00-13.00 Educational Workshop EW16 "Presentation of the ESCMID diagnostic & management guideline for Candida diseases 2011"
8 May, 12.30-13.30 (Room Amber 1) EFISG Business Meeting All interested persons are cordially invited to join the meeting and plan future EFISG activities.
For more details, please check the ECCMID/ICC programme.